| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00860930 |
| P698 | PubMed publication ID | 8580009 |
| P2093 | author name string | J R Burke | |
| P2860 | cites work | Management of the anaemia of chronic renal failure with recombinant erythropoietin | Q38760350 |
| Iron deficiency anemia: adverse effects on infant psychomotor development | Q39272810 | ||
| Anemia of end-stage renal disease (ESRD). | Q39830331 | ||
| Use of low-dose subcutaneous recombinant human erythropoietin in end-stage renal disease: experience with children receiving continuous cycling peritoneal dialysis | Q44285705 | ||
| Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis | Q46900551 | ||
| Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis | Q48888451 | ||
| Effects of kidney transplantation on cognitive performance in a pediatric population. | Q49012928 | ||
| A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis. | Q53662998 | ||
| Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis | Q67819859 | ||
| Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease | Q69554470 | ||
| Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis | Q69889300 | ||
| Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia | Q70522678 | ||
| Treatment of renal anemia by subcutaneous erythropoietin in children with preterminal chronic renal failure | Q72249554 | ||
| Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis | Q72249558 | ||
| Haemorheological changes in uraemic children in response to erythropoietin treatment | Q72959568 | ||
| P433 | issue | 5 | |
| P921 | main subject | New Zealand | Q664 |
| P304 | page(s) | 558-561 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Pediatric Nephrology | Q15749796 |
| P1476 | title | Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure. Australian and New Zealand Paediatric Nephrology Association | |
| P478 | volume | 9 |
| Q37042133 | Anemia and risk of hospitalization in pediatric chronic kidney disease |
| Q44481322 | Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. |
| Q79538360 | Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q79537550 | How to define anemia in children with chronic kidney disease? |
| Q73566942 | IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000 |
| Q73071326 | Intraperitoneal erythropoietin in children on peritoneal dialysis: A study of pharmacokinetics and efficacy |
| Q38134288 | Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease |
| Q34169794 | Risk factors for progression of chronic kidney disease |
Search more.